Nathaniel Bouganim

Department Of Otolaryngology Head And Neck Surgery
Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Neoadjuvant Capecitabine in Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Neoadjuvant Capecitabine in Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Journal: JAMA dermatology

Published: May 27, 2026

Correction to: A Canadian real‑world, multi‑center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2‑negative advanced breast cancer.

Correction to: A Canadian real‑world, multi‑center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2‑negative advanced breast cancer.

Journal: Breast cancer research and treatment

Published: March 19, 2026

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.

Journal: Current oncology (Toronto, Ont.)

Published: January 28, 2026

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).

Journal: Current oncology (Toronto, Ont.)

Published: January 16, 2026

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast Cancer 2025.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast Cancer 2025.

Journal: Current oncology (Toronto, Ont.)

Published: December 24, 2025

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025.

Journal: Current oncology (Toronto, Ont.)

Published: December 07, 2025

Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk index.

Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk index.

Journal: Oral oncology

Published: August 29, 2025

Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer.

Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer.

Journal: Head & neck

Published: July 13, 2025

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study.

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study.

Journal: Head & neck

Published: March 23, 2025

Fuel for Recovery: Predicting G-Tube Dependence in HPV-Negative Operable HNSCC.

Fuel for Recovery: Predicting G-Tube Dependence in HPV-Negative Operable HNSCC.

Journal: Head & neck

Published: March 20, 2025

Sarcopenia Trajectories Predict Survival in Operable Head and Neck Cancer.

Sarcopenia Trajectories Predict Survival in Operable Head and Neck Cancer.

Journal: Head & neck

Published: March 18, 2025

A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma.

A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: December 11, 2024

Showing 1-12 of 87

Last Updated: 09/26/2026